Caplight Directory>Companies>1910 Genetics-preview>1910-genetics


1910 Genetics

1910 Genetics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.1910genetics.com

Last Round

Strategic

Oct 31, 2024

Total Funding Raised

$26.65M

Company Overview

1910 Genetics is a biotechnology company that provides a drug discovery platform utilizing multimodal AI and laboratory automation to enhance productivity and reduce failure rates in small and large molecule drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Platform-as-a-Service

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS, Government Contracts

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformsmall molecule designprotein therapeutic designgenerative biologyAI biotechdrug discovery infrastructurein-silico drug discoveryrobotic automationundruggable targetswet lab automationcomputational biologyblood-brain barrier predictionmultimodal AIhigh-performance computingHPCPlatform-as-a-ServicePaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1910 Genetics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

1910 Genetics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicOct 31, 2024
GrantSep 30, 2021
Series AMar 23, 2021
View all Funding Rounds

1910 Genetics Investors

Notable investors and investment history

InvestorRounds
Scientia VenturesSeed, Series A
EmlesSeries A
NIH RADxGrant
FoundersX VenturesSeed
Playground GlobalSeries A
Accenture VenturesStrategic
Y CombinatorSeed
View all Investors

1910 Genetics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

1910 Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 1910 Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range42
Year Founded2018
Last FundingOct 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.